Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
Mar. 31, 2014
Dec. 31, 2013
Current assets:    
Cash and cash equivalents $ 76,673 $ 594,248
Short-term investment 39,383 39,375
Accounts receivable, net 238,631 246,519
Inventory 28,450 34,052
Prepaid expenses and other current assets 13,717 15,493
Total current assets 396,854 929,687
Equipment, net 11,587 11,867
Security deposit 12,000 12,000
Debt issuance costs, net 42,415 44,830
Totals 462,856 998,384
Current liabilities:    
Accounts payable and accrued expenses 257,329 306,144
Accrued interest, related party 30,657 28,636
Accrued interest 50,898 9,458
Related party accounts payable and accrued expenses 136,615 244,858
Related party notes payable 73,500 73,500
Convertible debentures, net of discounts of $151,665 and $269,388 1,920,335 1,802,612
Billings in excess of costs and estimated earnings on uncompleted contracts 22,615 24,349
Deferred revenue 177,006 379,765
Conversion option liabilities 2,490 2,873
Warrant liabilities 295,336 214,738
Total current liabilities 2,966,781 3,086,933
Commitments      
Stockholders' deficiency:    
Preferred stock, $0.01 par value, 5,000,000 shares authorized; 0 issued and outstanding at March 31, 2014 and December 31, 2013      
Common stock, $0.01 par value, 100,000,000 shares authorized; 43,273,093 issued and outstanding at March 31, 2014, 43,223,093 issued and outstanding at December 31, 2013 432,731 432,231
Additional paid-in capital 6,781,636 6,679,298
Accumulated deficiency (9,718,292) (9,200,078)
Accumulated other comprehensive loss      
Total stockholders' deficiency (2,503,925) (2,088,549)
Totals $ 462,856 $ 998,384